Suppr超能文献

剪接体抑制剂及其衍生物:强效剪接抑制剂的化学合成与生物学特性。

Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

机构信息

Department of Chemistry and Department of Medicinal Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.

Department of Molecular, Cell and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, California 95064, United States.

出版信息

J Nat Prod. 2021 May 28;84(5):1681-1706. doi: 10.1021/acs.jnatprod.1c00100. Epub 2021 May 11.

Abstract

Spliceostatins and thailanstatins are intriguing natural products due to their structural features as well as their biological significance. This family of natural products has been the subject of immense synthetic interest because they exhibit very potent cytotoxicity in representative human cancer cell lines. The cytotoxic properties of these natural products are related to their ability to inhibit spliceosomes. FR901564 and spliceostatins have been shown to inhibit spliceosomes by binding to their SF3B component. Structurally, these natural products contain two highly functionalized tetrahydropyran rings with multiple stereogenic centers joined by a diene moiety and an acyclic side chain linked with an amide bond. Total syntheses of this family of natural products led to the development of useful synthetic strategies, which enabled the synthesis of potent derivatives. The spliceosome modulating properties of spliceostatins and synthetic derivatives opened the door for understanding the underlying spliceosome mechanism as well as the development of new therapies based upon small-molecule splicing modulators. This review outlines the total synthesis of spliceostatins, synthetic studies of structural derivatives, and their bioactivity.

摘要

拼接抑素和泰兰他汀因其结构特征和生物学意义而成为引人注目的天然产物。由于它们在代表性的人类癌细胞系中表现出非常强的细胞毒性,因此这类天然产物引起了人们极大的合成兴趣。这些天然产物的细胞毒性与其抑制剪接体的能力有关。FR901564 和拼接抑素已被证明通过与 SF3B 成分结合来抑制剪接体。在结构上,这些天然产物包含两个高度官能化的四氢吡喃环,具有多个立体中心,由一个二烯部分和一个非循环侧链连接,通过酰胺键连接。该天然产物家族的全合成导致了有用的合成策略的发展,这些策略使合成具有强大活性的衍生物成为可能。拼接抑素及其合成衍生物的剪接体调节特性为理解潜在的剪接体机制以及基于小分子剪接调节剂的新疗法的开发打开了大门。本文综述了拼接抑素的全合成、结构衍生物的合成研究及其生物活性。

相似文献

1
Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.
J Nat Prod. 2021 May 28;84(5):1681-1706. doi: 10.1021/acs.jnatprod.1c00100. Epub 2021 May 11.
2
Design and synthesis of herboxidiene derivatives that potently inhibit splicing.
Org Biomol Chem. 2021 Feb 18;19(6):1365-1377. doi: 10.1039/d0ob02532a.
4
Syntheses of spliceostatins and thailanstatins: a review.
Beilstein J Org Chem. 2020 Aug 13;16:1991-2006. doi: 10.3762/bjoc.16.166. eCollection 2020.
5
Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic Analogues.
J Nat Prod. 2014 Aug 22;77(8):1864-70. doi: 10.1021/np500342m.
6
Total Synthesis of Thailanstatin A.
J Am Chem Soc. 2016 Jun 22;138(24):7532-5. doi: 10.1021/jacs.6b04781. Epub 2016 Jun 13.
7
Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
Molecules. 2021 Sep 30;26(19):5938. doi: 10.3390/molecules26195938.
9
Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.
Chemistry. 2011 Jan 17;17(3):895-904. doi: 10.1002/chem.201002402. Epub 2010 Nov 19.
10
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.
Nucleic Acids Res. 2010 Oct;38(19):6664-72. doi: 10.1093/nar/gkq494. Epub 2010 Jun 6.

引用本文的文献

1
Small molecules modulating RNA splicing: a review of targets and future perspectives.
RSC Med Chem. 2024 Jan 11;15(4):1109-1126. doi: 10.1039/d3md00685a. eCollection 2024 Apr 24.
2
Structural insights into branch site proofreading by human spliceosome.
Nat Struct Mol Biol. 2024 May;31(5):835-845. doi: 10.1038/s41594-023-01188-0. Epub 2024 Jan 9.
3
The Evolving Landscape of Antibody-Drug Conjugates: In Depth Analysis of Recent Research Progress.
Bioconjug Chem. 2023 Nov 15;34(11):1951-2000. doi: 10.1021/acs.bioconjchem.3c00374. Epub 2023 Oct 11.
4
Recent updates and future perspectives in aziridine synthesis and reactivity.
Chem. 2023 Jul 13;9(7):1658-1701. doi: 10.1016/j.chempr.2023.04.010. Epub 2023 May 11.
5
Stereochemical Control of Splice Modulation in FD-895 Analogues.
J Med Chem. 2023 May 25;66(10):6577-6590. doi: 10.1021/acs.jmedchem.2c01893. Epub 2023 May 8.

本文引用的文献

1
Total Synthesis of Meayamycin and -Acyl Analogues.
Org Lett. 2020 Nov 6;22(21):8714-8719. doi: 10.1021/acs.orglett.0c03308. Epub 2020 Oct 19.
2
Syntheses of spliceostatins and thailanstatins: a review.
Beilstein J Org Chem. 2020 Aug 13;16:1991-2006. doi: 10.3762/bjoc.16.166. eCollection 2020.
3
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
4
Total Synthesis of Meayamycin B.
J Org Chem. 2020 Apr 3;85(7):4637-4647. doi: 10.1021/acs.joc.9b03370. Epub 2020 Mar 23.
5
RNA Splicing by the Spliceosome.
Annu Rev Biochem. 2020 Jun 20;89:359-388. doi: 10.1146/annurev-biochem-091719-064225. Epub 2019 Dec 3.
6
Enantioselective Synthesis of a Cyclopropane Derivative of Spliceostatin A and Evaluation of Bioactivity.
Org Lett. 2018 Nov 16;20(22):7293-7297. doi: 10.1021/acs.orglett.8b03228. Epub 2018 Nov 5.
8
Enantioselective Synthesis of Thailanstatin A Methyl Ester and Evaluation of in Vitro Splicing Inhibition.
J Org Chem. 2018 May 4;83(9):5187-5198. doi: 10.1021/acs.joc.8b00593. Epub 2018 Apr 26.
9
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
Mol Cell. 2018 Apr 19;70(2):265-273.e8. doi: 10.1016/j.molcel.2018.03.011. Epub 2018 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验